Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.865936 USD
38.76 M USD
72.34 M USD
16.27 M
About OSE Immunotherapeutics SA
Sector
Industry
CEO
Marc Le Bozec
Website
Headquarters
Nantes
Founded
2004
IPO date
Mar 30, 2015
Identifiers
2
ISIN FR0012127173
OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and partnering therapies to control the immune system for immuno-oncology and immuno-inflammation. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ORPOF is 11.600000 USD — it has increased by 190.00% in the past 24 hours. Watch OSE Immunotherapeutics SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange OSE Immunotherapeutics SA stocks are traded under the ticker ORPOF.
We've gathered analysts' opinions on OSE Immunotherapeutics SA future price: according to them, ORPOF price has a max estimate of 24.84 USD and a min estimate of 12.54 USD. Watch ORPOF chart and read a more detailed OSE Immunotherapeutics SA stock forecast: see what analysts think of OSE Immunotherapeutics SA and suggest that you do with its stocks.
ORPOF reached its all-time high on Dec 27, 2021 with the price of 11.600000 USD, and its all-time low was 3.950400 USD and was reached on Feb 7, 2019. View more price dynamics on ORPOF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ORPOF stock is 65.52% volatile and has beta coefficient of 1.35. Track OSE Immunotherapeutics SA stock price on the chart and check out the list of the most volatile stocks — is OSE Immunotherapeutics SA there?
Today OSE Immunotherapeutics SA has the market capitalization of 116.22 M, it has increased by 4.66% over the last week.
Yes, you can track OSE Immunotherapeutics SA financials in yearly and quarterly reports right on TradingView.
OSE Immunotherapeutics SA is going to release the next earnings report on Apr 1, 2026. Keep track of upcoming events with our Earnings Calendar.
ORPOF net income for the last half-year is −17.79 M USD, while the previous report showed −20.42 M USD of net income which accounts for 12.88% change. Track more OSE Immunotherapeutics SA financial stats to get the full picture.
No, ORPOF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 64 employees. See our rating of the largest employees — is OSE Immunotherapeutics SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OSE Immunotherapeutics SA EBITDA is −48.70 M USD, and current EBITDA margin is 40.58%. See more stats in OSE Immunotherapeutics SA financial statements.
Like other stocks, ORPOF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OSE Immunotherapeutics SA stock right from TradingView charts — choose your broker and connect to your account.